"Adrenergic beta-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively bind to and activate beta-adrenergic receptors.
| Descriptor ID |
D000318
|
| MeSH Number(s) |
D27.505.519.625.050.100.200 D27.505.696.577.050.100.200
|
| Concept/Terms |
Adrenergic beta-Agonists- Adrenergic beta-Agonists
- Adrenergic beta Agonists
- beta-Agonists, Adrenergic
- Adrenergic beta-Receptor Agonist
- Adrenergic beta Receptor Agonist
- Agonist, Adrenergic beta-Receptor
- beta-Receptor Agonist, Adrenergic
- Adrenergic beta-Receptor Agonists
- Adrenergic beta Receptor Agonists
- Agonists, Adrenergic beta-Receptor
- beta-Receptor Agonists, Adrenergic
- beta-Adrenergic Agonist
- Agonist, beta-Adrenergic
- beta Adrenergic Agonist
- Receptors Agonists, Adrenergic beta
- beta-Adrenergic Receptor Agonist
- Agonist, beta-Adrenergic Receptor
- Receptor Agonist, beta-Adrenergic
- beta Adrenergic Receptor Agonist
- beta-Adrenergic Receptor Agonists
- Agonists, beta-Adrenergic Receptor
- beta Adrenergic Receptor Agonists
- Betamimetics
- Receptor Agonists, beta-Adrenergic
- Receptor Agonists, beta Adrenergic
- Adrenergic beta-Agonist
- Adrenergic beta Agonist
- beta-Agonist, Adrenergic
- beta-Adrenergic Agonists
- Agonists, beta-Adrenergic
- beta Adrenergic Agonists
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Agonists".
This graph shows the total number of publications written about "Adrenergic beta-Agonists" by people in this website by year, and whether "Adrenergic beta-Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 3 | 4 |
| 2001 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic beta-Agonists" by people in Profiles.
-
Limited Impact of ß-Adrenergic Receptor Activation on Left Ventricular Diastolic Function in Rat Models of Hypertensive Heart Disease. J Cardiovasc Pharmacol. 2018 11; 72(5):242-251.
-
Prevention of ßeta-adrenergic-induced Adverse Cardiac Remodeling by Gonadectomy in Male but Not Female Spontaneously Hypertensive Rats. J Cardiovasc Pharmacol. 2017 Sep; 70(3):202-209.
-
Impact of castration on changes in left ventricular diastolic pressure-volume relations induced by chronic adrenergic stimulation in rats. J Cardiovasc Pharmacol. 2014 Jun; 63(6):562-6.
-
Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats. Eur J Appl Physiol. 2013 Nov; 113(11):2803-11.
-
Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction. Basic Res Cardiol. 2012 Jan; 107(1):238.
-
Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats. J Cardiovasc Pharmacol. 2010 Aug; 56(2):203-11.
-
Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats. Pflugers Arch. 2007 Nov; 455(2):251-60.
-
Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1898-905.
-
Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats. Eur J Pharmacol. 2006 Dec 28; 553(1-3):246-53.
-
Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation. Pflugers Arch. 2006 May; 452(2):155-63.